Verteporfin sets its sights on new disorders

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1275, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US FDA sets its sights on the developing world

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Verteporfin

By Scott L.J.   Goa K.L.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularisation

By Fenton Caroline   Perry Caroline M.  

Drugs & Aging, Vol. 23, Iss. 5, 2006-01 ,pp. : 421-445

Adis International

Access to resources Recommend Favorite

Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularisation

By Keam S.J.   Scott L.J.   Curran M.P.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2521-2554

Adis International

Access to resources Recommend Favorite

Verteporfin launched in the UK

By  

Inpharma, Vol. 1, Iss. 1252, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite